<p>In the Special Issue several experts from all over the world report and discuss the most recent advances from basic science to the clinical management of HPV-related malignancies especially highlighting the oncogenic role of epigenetic factors viral proteins and the immune response in HPV-driven cancers as well as&nbsp;new anti-cancer opportunities including HPV-based therapeutic vaccines.</p>